Veraxa Biotech Holding AG F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
NASDAQ
Veraxa Biotech Holding AG files an amendment to its F-1 registration statement, primarily to include exhibits and address legal counsel opinions regarding share issuances.
NASDAQ
Veraxa Biotech Holding AG files an amendment to its F-1 registration statement, primarily to include exhibits and legal opinions related to its securities.
NASDAQ
Veraxa Biotech AG has filed a registration statement with the SEC for up to 19,436,739 ordinary shares underlying warrants, 6,786,739 private warrants, and 120,295,385 ordinary shares.
NASDAQ
Veraxa Biotech AG has filed a registration statement for the resale of up to 25,000,000 ordinary shares by Lincoln Park Capital Fund, LLC, following a business combination and financing arrangements.